Skip to main content

Grafa News and Videos — Page 1175

Latest

Grafa

GSK and Ionis present pivotal data showing 19% functional cure for chronic hepatitis B

GSK (NYSE:GSK) and partner Ionis Pharmaceuticals (NASDAQ:IONS) announced positive data from two pivotal Phase 3 trials evaluating bepirovirsen, an investigational antisense oligonucleotide designed to treat chronic hepatitis B.

Read more: GSK and Ionis present pivotal data showing 19% functional cure for chronic hepatitis B

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift